Invesco
LJPC

Invesco’s La Jolla Pharmaceutical Company LJPC Stock Holding History

Invesco’s Portfolio LJPC Stock Details LJPC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q4 		– Sell
-85,021
Closed -$748K – 3790
2019
Q3 		$748K Buy
+85,021
New +$803K ﹤0.01% 3122
2015
Q3 		– Sell
-2,991
Closed -$73K – 4332
2015
Q2 		$73K Buy
+2,991
New +$61.6K ﹤0.01% 3934

Other funds holding LJPC

TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
BC
Broadfin Capital New York $747M AUM 100.56% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BC
Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return
Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $35.4B AUM 33.54% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Invesco's LJPC Position: Q4 2019 in Review

Invesco sold out of La Jolla Pharmaceutical Company (LJPC) in Q4 2019, closing a stake of 85,021 shares — an estimated $748K sold.

Invesco first reported a position in LJPC in Q2 2015 and held it in 2 quarters. The position peaked at $748K in Q3 2019. 77 funds tracked by Wall St. Rank hold LJPC as of Q4 2019.

  • Invesco reported no remaining La Jolla Pharmaceutical Company position as of Q4 2019 after selling out during the quarter.
  • Invesco sold 85,021 La Jolla Pharmaceutical Company shares in Q4 2019, an estimated $748K.
  • Invesco first reported a position in La Jolla Pharmaceutical Company in Q2 2015 and held it in 2 quarters.
  • Invesco's La Jolla Pharmaceutical Company position peaked at $748K in Q3 2019.
  • 77 funds tracked by Wall St. Rank held La Jolla Pharmaceutical Company as of Q4 2019.

Based on Invesco's 13F filing for Q4 2019, filed 14 Feb 2020.